SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-17-000901
Filing Date
2017-03-27
Accepted
2017-03-27 07:30:44
Documents
15
Period of Report
2017-03-27

Document Format Files

Seq Description Document Type Size
1 6-K zk1719739.htm 6-K 14875
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 19365
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 20586
4 exhibit_99-2slide1.jpg GRAPHIC 68223
5 exhibit_99-2slide2.jpg GRAPHIC 236567
6 exhibit_99-2slide3.jpg GRAPHIC 75089
7 exhibit_99-2slide4.jpg GRAPHIC 131022
8 exhibit_99-2slide5.jpg GRAPHIC 121255
9 exhibit_99-2slide6.jpg GRAPHIC 106217
10 exhibit_99-2slide7.jpg GRAPHIC 98868
11 exhibit_99-2slide8.jpg GRAPHIC 107427
12 exhibit_99-2slide9.jpg GRAPHIC 102973
13 exhibit_99-2slide10.jpg GRAPHIC 120838
14 exhibit_99-2slide11.jpg GRAPHIC 117985
15 exhibit_99-2slide12.jpg GRAPHIC 40099
  Complete submission text file 0001178913-17-000901.txt   1884112
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36621 | Film No.: 17714172
SIC: 2833 Medicinal Chemicals & Botanical Products